A drug with the SMILES COc1ccc2nc(SCC(=O)Nc3ccc(S(=O)(=O)Nc4nccc(C)n4)cc3)[nH]c2c1 has a human ether-à-go-go related gene (hERG) inhibition at a concentration of 10uM of -1.000%.
A {#drug|compound!} with the {SMILES__description} {SMILES#} has a {herg_central_at_10uM__names__noun} of {herg_central_at_10uM#}{herg_central_at_10uM__units}.
COc1ccc2nc(SCC(=O)Nc3ccc(S(=O)(=O)Nc4nccc(C)n4)cc3)[nH]c2c1
COc1ccc2nc(SCC(=O)Nc3ccc(S(=O)(=O)Nc4nccc(C)n4)cc3)[nH]c2c1
2-[(6-methoxy-1H-benzimidazol-2-yl)sulfanyl]-N-[4-[(4-methylpyrimidin-2-yl)sulfamoyl]phenyl]acetamide